Sunnyvale, California (ots/PRNewswire) - Robotic Radiosurgery System's Unique Motion Management Technique Limits Toxicity and Preserves Cosmesis in Convenient, 5-Fraction Treatment Regimen Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase I clinical trial evaluating ...
Lund, Sweden and Princeton, New Jersey (ots/PRNewswire) - New data support long-term safety and efficacy of weekly and monthly subcutaneous buprenorphine depots in patients with opioid use disorder Camurus (NASDAQ STO: CAMX) and Braeburn Pharmaceuticals today announced positive top-line results from a long-term ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts and Durham, North Carolina (ots/PRNewswire) - Demonstrates ongoing commitment to innovation in ophthalmics for Shire P-321 is a Phase 2 investigational topical treatment for dry eye disease Shire plc (LSE: SHP, NASDAQ: SHPG) and Parion Sciences, Inc. today announced they have entered into an ...
Darmstadt, Germany (ots/PRNewswire) - - Subgroup analysis shows >80% reduction in the risk of disability progression with Cladribine Tablets vs placebo Merck, a leading science and technology company, announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in ...
Munich (ots/PRNewswire) - - ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients following successful transcatheter aortic valve implantation - Study adds to the growing Edoxaban Clinical Research Programme (ECRP) ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - Natpar is the first and only licensed recombinant human parathyroid hormone therapy for chronic hypoparathyroidism Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the European Commission (EC) has granted Conditional Marketing Authorisation for Natpar (rhPTH[1-84]), the ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - Shire launches campaign to raise global awareness during World PI Week Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, is launching #PIPostsThanks, a social campaign to spotlight the unsung heroes who make a difference in the lives of people living with primary immunodeficiency (PI). PI is a group of nearly ...
Vienna (ots/PRNewswire) - CDI, a potentially fatal disease,[2] is three times as deadly as MRSA[3],[4] and is estimated to cost the EU EUR3 billion per annum[5] New data presented today at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017, demonstrate benefits of ...
Darmstadt, Germany (ots/PRNewswire) - - Breadth of data and activities underscore company's long-standing commitment to enhancing care for people with MS Merck, a leading science and technology company, will present data at the American Academy of Neurology (AAN) 69th Annual Meeting, taking place from April 22-28, ...
Vienna (ots/PRNewswire) - CDI is one of the top ten hospital-acquired infections (HAIs) in European Hospitals[1] and is estimated to be three times as deadly as MRSA[2],[3] Data released at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2017 demonstrate the impact of CDI on the ...
Haifa, Israel (ots/PRNewswire) - INSIGHTEC (https://goo.gl/knr17E) congratulates Nicklaus Children's Hospital (https://www.nicklauschildrens.org/home), part of the Miami Children's Health System, for performing the first focused ultrasound procedure on a 21-year old patient suffering seizures associated with a ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - On World Hemophilia Day 2017, Shire challenges the community to collectively improve global standards of care for rare bleeding disorders Shire plc (LSE: SHP, NASDAQ: SHPG), a leading biotechnology company focused on serving individuals with rare diseases, joins the global ...
Sunnyvale, California (ots/PRNewswire) - Premier Algerian Cancer Center Now Provides Cancer Patients with Leading-Edge Radiation Treatments Accuray Incorporated (NASDAQ: ARAY) announced today that the newly built Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria is now treating cancer patients with the first TomoTherapy® Systems installed in Africa. ...
Sunnyvale, California (ots/PRNewswire) - Partnership Creates Strategic Alliance for Clinical Education and Training in Robotic Radiosurgery Accuray Incorporated (NASDAQ: ARAY) announced today the signing of a three-year Collaboration and Support Agreement with the N.N. Burdenko National Scientific and Practical ...
Royal Philips and B. Braun Melsungen AG
Melsungen, Germany and Amsterdam (ots/PRNewswire) - - Strategic alliance combines B. Braun's leadership in regional anesthesia and Philips' leadership in image guided therapy solutions with the aim to make regional anesthesia and vascular access easier to perform, leading to enhanced patient care and hospital ...
Orlando, Florida (ots/PRNewswire) - Abstract #620 Findings from a post hoc analysis of the phase 3a SUSTAIN 2-4 trials demonstrated greater mean reductions in HbA1c and body weight with once-weekly semaglutide treatment compared to sitagliptin, exenatide extended release (ER) and insulin glargine U100 in adults with ...
Munich (ots/PRNewswire) - - Study adds to the growing Edoxaban Clinical Research Programme (ECRP) evaluating its use in a broad range of cardiovascular conditions, patient types and clinical settings Daiichi Sankyo Europe GmbH (hereafter, "Daiichi Sankyo") today announced that the first patient has been enrolled ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - A New Non-stimulant Clinical Option for Children and Adolescents From 6 to 17 Years old With ADHD Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that its partner in Japan, Shionogi & Co., Ltd, has received the approval of the Japanese Ministry of Health, Labor and Welfare to ...
Takeda Pharmaceutical Company Limited
Zurich (ots/PRNewswire) - Takeda Pharmaceutical Company Limited ("Takeda") announced today that Giles Platford will assume the role of President of the Europe and Canada (EUCAN) Business Unit of Takeda. In this role he will lead business operations in the region effective April 1, 2017. Giles Platford, who joined Takeda in 2009, is also a Corporate Officer and member ...
Toulouse and Archamps, France (ots/PRNewswire) - Dr. Philippe Lluel from Urosphere, a company specialized in preclinical pharmacology of urogenital tract, presented on behalf of all investigators two scientific posters at the prestigious congress of the European Association of Urology (EAU) in London, showing for ...
Bagsværd, Denmark (ots/PRNewswire) - Canada first country to launch Fiasp® This material is intended for global medical media only. For journalistic assessment and preparation before publication. Today, Novo Nordisk announced that Fiasp®, a new, fast-acting mealtime insulin for the treatment of diabetes in ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for UK-based media - Only FDA-approved treatment for metastatic Merkel cell carcinoma, a rare and aggressive skin cancer - First indication for BAVENCIO, a human anti-PD-L1 antibody Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and ...
Brussels (ots/PRNewswire) - During the "Nudging for Good" Awards Ceremony presented in Brussels, My UV Patch, La Roche-Posay's digital breakthrough innovation to change bad sun habits into life-saving ones, was awarded the Diamond Award by the European Brands Association (AIM). Launched in 2016, the "Nudging for Good" Award aims to honor brands that make it easy and ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - CINRYZE is now the first and only Hereditary angioedema treatment approved for routine prevention in paediatrics Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor ...
European Hematology Association (EHA)
Vilnius, Lithuania (ots/PRNewswire) - Patients suffering from rare blood disorders will benefit from networks of excellence across the European Member States. At the third conference on European Reference Networks (ERNs) yesterday in Vilnius, Lithuania, EuroBloodNet was officially awarded as one of the recently approved ERNs. ERNs is an initiative of the European ...
Lestrem, France (ots/PRNewswire) - Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries Roquette, a global leader in innovative plant-based pharmaceutical ingredients, announces its commitment to provide new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. (Logo: ...
Darmstadt, Germany (ots/PRNewswire) - - Merck integrates innovative Eeva® Test with Geri(TM) incubation platform, bringing individualized incubation and outcome prediction together - Geri(TM) humidity technology aims to further advance incubation to precisely monitor and manage the humidity level in the incubator Merck, a leading science and technology company, today ...
Kaiseraugst, Switzerland (ots/PRNewswire) - - Breakthrough for animal nutrition to reduce impact on ocean resources and making it more sustainable - Commercial-scale facility for algal oil for salmon aquaculture and pet food to be built in the United States - Further develop and produce a high value algal oil with a ...
Lausanne (ots) - Change in name reflects new strategy to invest in smart data, therapeutics and diagnostics Debiopharm Diagnostics SA, the strategic investment fund of Debiopharm Group(TM) (www.debiopharm.com), announced its new strategy and the change of name to Debiopharm Innovation Fund SA effective today. With the aim of speeding up innovations that radically ...